6 not yet recruiting, 2 enrolling by invitation, 1 recruiting. 5 Not applicable, 2 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Not yet recruiting 3, Enrolling by invitation 1, Recruiting 1 |
| Phase 2 | 2 | Not yet recruiting 2 |
| Phase 3 | 1 | Not yet recruiting 1 |
| Phase 4 | 1 | Enrolling by invitation 1 |
Follow RCT: new trials by email Literature Review of RCT trials Research Report on RCT
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of iPSC-Derived Motor Neuron Cells (XS228) in Subacute Spinal Cord Injury: A Phase II Randomized Controlled Trial Allogeneic Human Induced Pluripotent Stem Cell (iPSC)-Derived Motor Neuron Progenitor Cells, Placebo - Spinal Cord Injury, Safety | Phase 2 | Not yet recruiting | XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. | 60 | 2028-05-25 | 2025-11-25 |
| Anti-PCSK9 Antibody Tafolecimab and Anti-PD-1 Antibody Sintilimab Combined With Neoadjuvant Chemoradiotherapy for pMMR/ MSS Locally Advanced Rectal Cancer : A Prospective, Multicenter, Randomized, Open-Label, Parallel-Controlled Trial Short-course radiotherapy, CAPOX (oxaliplatin/capecitabine), Sintilimab - Local Advanced Rectal Cancer, PD-1 Inhibitor | Phase 3 | Not yet recruiting | Guangdong Provincial People's Hospital | 148 | 2027-01-01 | 2026-07-07 |
| Designing a Smoking Intervention for Youth Smokers typology-based intervention, Routine Treatment - Smoking (Tobacco) Addiction, Young Adult | Not applicable | Not yet recruiting | The University of Hong Kong | 100 | 2026-06-05 | 2026-06-02 |
| Salivary Gland Massage and Olfactory Stimulation for Relieving Feeding Difficulty and Triggering Oral Intake Among People With Dementia SMART program (Salivary gland massage combined with aromatherapy - Experimental, Dementia | Not applicable | Enrolling by invitation | National Cheng Kung University | 30 | 2026-03-16 | 2026-07-01 |
| Continuous Vital Sign Monitoring Versus Routine Spot-checks in Patients After Non-cardiac Surgery Unblinded continuous vital sign monitoring, Blinded continuous vital sign monitoring - Vital Sign Monitoring, Post Operative Complications | Not applicable | Recruiting | Universitätsklinikum Hamburg-Eppendorf | 264 | 2026-02-24 | 2026-03-02 |
| Perioperative Ivonescimab Plus S-1 and Oxaliplatin (SOX) for Locally Advanced Gastric or GEJ Adenocarcinoma Ivonescimab (20mg/kg Q3W), Oxaliplatin, S-1 - Gastric Cancer, RCT | Phase 2 | Not yet recruiting | Sichuan University | 154 | 2026-02-01 | 2026-01-28 |
| Safety and Efficacy of Connecting the Residual Ear to the Cartilage Scaffold in First- vs. Second-Stage Surgery Two-stage connection, One-stage connection - Microtia, Outcome Assessment | Not applicable | Not yet recruiting | Sichuan Provincial People's Hospital | 78 | 2025-06-01 | 2025-05-16 |
| Effect of Blue Light Blocking on Reducing Manic Symptoms in Bipolar Disorder Blue-blocking glasses, Clear glasses - Bipolar, Manic | Not applicable | Not yet recruiting | Rayan NASSERDINE | 96 | 2025-04-01 | 2024-12-27 |
| Cabergoline in the Management of Nonfunctioning Pituitary Adenoma Cabergoline 0.5 MG - Pituitary Adenoma, MRI | Phase 4 | Enrolling by invitation | National Taiwan University Hospital | 30 | 2024-05-20 | 2025-06-24 |
Behavior, Addictive (1) · Bipolar Disorder (1) · Congenital Microtia (1) · Dementia (1) · Hypotension (1) · Mania (1) · Pituitary Neoplasms (1) · Smoking (1) · Smoking Cessation (1) · Spinal Cord Injuries (1) · Stomach Neoplasms (1) · Xerostomia (1)
Nervous System Diseases (4) · Central Nervous System Diseases (3) · Brain Diseases (2) · Mental Disorders (2) · Neoplasms (2) · Neoplasms by Site (2) · Behavior (1) · Bipolar and Related Disorders (1) · Brain Neoplasms (1) · Cardiovascular Diseases (1) · Central Nervous System Neoplasms (1) · Compulsive Behavior (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Digestive System Diseases (1)
Oxaliplatin (2) · Aromatherapy (1) · Cabergoline (1) · Capecitabine (1) · S 1 (combination) (1) · sintilimab (1)
Guangdong Provincial People's Hospital (1) · National Cheng Kung University (1) · National Taiwan University Hospital (1) · Rayan NASSERDINE (1) · Sichuan Provincial People's Hospital (1) · Sichuan University (1) · The University of Hong Kong (1) · Universitätsklinikum Hamburg-Eppendorf (1) · XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. (1)
China (4) · Taiwan (2) · Germany (1) · Hong Kong (1) · Switzerland (1)
Bernd Saugel, MD (1) · Gou Hongfeng (1) · Limin Rong, prof and M.D (1)
PMID 24737677, PMID 31513484, PMID 32606208, PMID 33538338, PMID 33792646, PMID 33852952, PMID 34796431, PMID 35969830, PMID 36603169, PMID 37963317, PMID 41638738
2023 (1)